CSIMarket


Corcept Therapeutics Inc  (CORT)
Other Ticker:  
 

Corcept Therapeutics Inc

CORT's Fundamental analysis






Corcept Therapeutics Inc's sales fell by -14.81 % in I. Quarter 2021 from the same quarter a year ago. Ranking at No. 2957

Major Pharmaceutical Preparations industry recorded growth of revenues by 14.66 %

Corcept Therapeutics Inc's net profit deacreased by -21.95 % in I. Quarter 2021 year on year, to $23 millions.

More on CORT's Growth


Corcept Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Corcept Therapeutics Inc realized cash outflow of $ -0.25per share in trailing twelve-month period.
Company
28.67
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.58.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.16.

Corcept Therapeutics Inc Price to Book Ratio is at 5.71 lower than Indusry Avg. of 2031.21. and higher than S&P 500 Avg. of -0

More on CORT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 14.61
 Tangible Book Value (Per Share $) 3.94

Corcept Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Corcept Therapeutics Inc realized cash outflow of $ -0.25per share in trailing twelve-month period.
Company
28.67
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.58.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.16.

Corcept Therapeutics Inc Price to Book Ratio is at 5.71 lower than Indusry Avg. of 2031.21. and higher than S&P 500 Avg. of -0

More on CORT's Valuation

  Market Capitalization (Millions $) 2,918
  Shares Outstanding (Millions) 130
  Employees -
  Revenues (TTM) (Millions $) 340
  Net Income (TTM) (Millions $) 99
  Cash Flow (TTM) (Millions $) -32
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 14.61
  Tangible Book Value (Per Share $) 3.94

  Market Capitalization (Millions $) 2,918
  Shares Outstanding (Millions) 130
  Employees -
  Revenues (TTM) (Millions $) 340
  Net Income (TTM) (Millions $) 99
  Cash Flow (TTM) (Millions $) -32
  Capital Exp. (TTM) (Millions $) -1

CORT's Profitability Comparisons
Corcept Therapeutics Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2021 to 24.72 % from 35.59 % in IV. Quarter.

Corcept Therapeutics Inc net profit margin of 29.54 % is currently ranking no. 20 in Major Pharmaceutical Preparations industry, ranking no. 37 in Healthcare sector and number 609 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 10.09
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.08
  Asset Turnover Ratio (TTM) 0.63
  Inventory Turnover Ratio (TTM) 1.01



Corcept Therapeutics Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2021 to 24.72 % from 35.59 % in IV. Quarter.

Corcept Therapeutics Inc net profit margin of 29.54 % is currently ranking no. 20 in Major Pharmaceutical Preparations industry, ranking no. 37 in Healthcare sector and number 609 in S&P 500.

More on CORT's Key Ratios





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

YTPG's Profile

Stock Price

YTPG's Financials

Business Description

Fundamentals

Charts & Quotes

YTPG's News

Suppliers

YTPG's Competitors

Customers & Markets

Economic Indicators

YTPG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071